Published in Cytotechnology on January 01, 2000
Proliferation control strategies to improve productivity and survival during CHO based production culture : A summary of recent methods employed and the effects of proliferation control in product secreting CHO cell lines. Cytotechnology (2007) 1.63
MicroRNAs: recently discovered key regulators of proliferation and apoptosis in animal cells : Identification of miRNAs regulating growth and survival. Cytotechnology (2007) 0.96
CHO microRNA engineering is growing up: recent successes and future challenges. Biotechnol Adv (2013) 0.84
Apoptosis and its suppression in hepatocytes culture. Cytotechnology (2005) 0.75
Optimization of heterologous protein production in Chinese hamster ovary cells under overexpression of spliced form of human X-box binding protein. BMC Biotechnol (2014) 0.75
Comparative Proteomic Analysis of Three Chinese Hamster Ovary (CHO) Host Cells. Biochem Eng J (2017) 0.75
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A (1992) 35.45
Mitochondria and apoptosis. Science (1998) 23.41
Caspases: enemies within. Science (1998) 19.45
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (1997) 16.09
The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08
The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (1997) 15.25
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66
p53: puzzle and paradigm. Genes Dev (1996) 13.16
Caspases: the executioners of apoptosis. Biochem J (1997) 11.99
Social controls on cell survival and cell death. Nature (1992) 9.81
Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene (1988) 6.13
DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell (1997) 5.95
Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A (1986) 5.54
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol (1990) 5.26
Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science (1997) 3.07
The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A (1995) 2.90
Positive selection of lymphocytes. Cell (1994) 2.86
Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene (1997) 2.70
Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev (1996) 2.30
Apoptosis: molecular regulation of cell death. Eur J Biochem (1996) 2.29
bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res (1992) 2.15
Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol (1998) 2.11
Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A (1997) 1.82
Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell. Oncogene (1989) 1.74
Dicistronic transcription units for gene expression in mammalian cells. Gene (1993) 1.66
Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J Biol Chem (1990) 1.50
Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells. Biotechnol Bioeng (1994) 1.47
Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured model. Biotechnol Prog (1990) 1.46
Growth rate suppression of cultured mammalian cells enhances protein productivity. Cytotechnology (1994) 1.43
Cell death in bioreactors: a role for apoptosis. Biotechnol Bioeng (1994) 1.23
A novel cytostatic process enhances the productivity of Chinese hamster ovary cells. Biotechnol Bioeng (1997) 1.23
Overexpression of bcl-2, apoptosis suppressing gene: Prolonged viable culture period of hybridoma and enhanced antibody production. Biotechnol Bioeng (1995) 1.20
Death mechanisms of animal cells in conditions of intensive agitation. Biotechnol Bioeng (1995) 1.18
Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures. Cytotechnology (1992) 1.13
Cell death (apoptosis) in cell culture systems. Trends Biotechnol (1995) 1.12
Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. Biotechnol Bioeng (1997) 1.09
pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells. Biotechnol Bioeng (1998) 1.05
O6-alkylguanine DNA lesions trigger apoptosis. Carcinogenesis (1998) 1.05
In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl-2 gene. Biotechnol Bioeng (1998) 1.04
The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2. Photochem Photobiol (1996) 1.02
Enhancement of survivability of mammalian cells by overexpression of the apoptosis-suppressor gene bcl-2. Biotechnol Bioeng (1996) 1.00
Hybridoma growth and monoclonal antibody production in iron-rich protein-free medium: effect of nutrient concentration. Cytotechnology (1991) 0.98
BCL-2 and MCL-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine. Exp Cell Res (1996) 0.94
Higher productivity of growth-arrested Chinese hamster ovary cells expressing the cyclin-dependent kinase inhibitor p27. Biotechnol Prog (1998) 0.94
Overcoming apoptosis: new methods for improving protein-expression systems. Trends Biotechnol (1998) 0.93
Molecular regulation of cell-cycle progression and apoptosis in mammalian cells: implications for biotechnology. Biotechnol Prog (1999) 0.92
Jaw1, A lymphoid-restricted membrane protein localized to the endoplasmic reticulum. J Immunol (1994) 0.92
Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle. Cytotechnology (1997) 0.92
Factors controlling cell proliferation and antibody production in mouse hybridoma cells: I. Influence of the amino acid supply. Biotechnol Bioeng (1991) 0.91
Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas. Cytotechnology (1993) 0.91
Regulated expression vectors demonstrate cell-type-specific sensitivity to human immunodeficiency virus type 1 Nef-induced cytostasis. J Gen Virol (1997) 0.91
Long-term perfusion culture of hybridoma: a "grow or die" cell cycle system. Biotechnol Bioeng (1991) 0.90
Distinct alterations in mitochondrial mass and function characterize different models of apoptosis. Exp Cell Res (1998) 0.90
NSO myeloma cell death: Influence of bcl-2 overexpression. Biotechnol Bioeng (1996) 0.87
Effect of bcl-2 expression on hybridoma cell growth in serum-supplemented, protein-free and diluted media. Cytotechnology (1998) 0.87
Improvement of the culture stability of non-anchorage-dependent animal cells grown in serum-free media through immobilization. Cytotechnology (1995) 0.86
The Bcl-2 family and cell death regulation. Curr Opin Genet Dev (1998) 0.86
Apoptosis and host restriction of vaccinia virus in RK13 cells. Virus Res (1997) 0.85
On the use of double FLP recognition targets (FRTs) in the LTR of retroviruses for the construction of high producer cell lines. Nucleic Acids Res (1996) 0.84
Apoptosis in CHO cell batch cultures: examination by flow cytometry. Cytotechnology (1995) 0.84
Growth factor and bcl-2 mediated survival during abortive proliferation of hybridoma cell line. Biotechnol Bioeng (1998) 0.84
Protection of B lymphocyte hybridoma against starvation-induced apoptosis: survival-signal role of some amino acids. Immunol Lett (1996) 0.83
Intracellular calcium stores are not required for Bcl-2-mediated protection from apoptosis. J Biol Chem (1996) 0.83
Kinetic studies on hybridoma cells immobilized in fixed bed reactors. Biotechnol Bioeng (1997) 0.81
Modulation of cell cycle progression and of antibody production in mouse hybridomas by a nucleotide analogue. Cytotechnology (1998) 0.80
Influence of bcl-2 on antibody productivity in high cell density perfusion cultures of hybridoma. Cytotechnology (1999) 0.79
Lack of induction of tissue transglutaminase but activation of the preexisting enzyme in c-Myc-induced apoptosis of CHO cells. Biochem Biophys Res Commun (1997) 0.78
Subcellular localization of bcl-2 protein. Curr Top Microbiol Immunol (1992) 0.78
Apoptosis regulation and its applications to biotechnology. Trends Biotechnol (1998) 0.77
The sequence of the human genome. Science (2001) 101.55
THE RELATION OF SERUM BICARBONATE CONCENTRATION TO MUSCLE COMPOSITION. J Clin Invest (1948) 7.94
State of the art in continuous speech recognition. Proc Natl Acad Sci U S A (1995) 6.69
Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol (2000) 3.70
Deletion mutations affecting autonomously replicating sequence ARS1 of Saccharomyces cerevisiae. Mol Cell Biol (1984) 3.53
Metabolic flux responses to pyruvate kinase knockout in Escherichia coli. J Bacteriol (2002) 3.06
A mathematical model of caspase function in apoptosis. Nat Biotechnol (2000) 2.85
Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics (2000) 2.73
Tennessee's failed managed care program for mental health and substance abuse services. JAMA (1998) 2.49
Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol (1999) 2.44
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin. Antimicrob Agents Chemother (1992) 2.39
Metabolic flux ratio analysis of genetic and environmental modulations of Escherichia coli central carbon metabolism. J Bacteriol (1999) 2.27
Multi-component apparent diffusion coefficients in human brain. NMR Biomed (1999) 2.21
Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol (1998) 2.11
Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol (2000) 1.98
Pleasant activities and depression. J Consult Clin Psychol (1973) 1.91
Metabolic fluxes in riboflavin-producing Bacillus subtilis. Nat Biotechnol (1997) 1.88
Effect of ARS1 mutations on chromosome stability in Saccharomyces cerevisiae. Mol Cell Biol (1985) 1.85
Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine. Med Phys (1999) 1.82
The anatomy and histology of the inferior glenohumeral ligament complex of the shoulder. Am J Sports Med (1991) 1.82
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol (2001) 1.81
Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost (2003) 1.81
The prevalence of celiac disease in at-risk groups of children in the United States. J Pediatr (2000) 1.76
DNA rearrangement of a homeobox gene in myeloid leukaemic cells. EMBO J (1988) 1.75
Why Britain can't afford informed consent. Hastings Cent Rep (1985) 1.73
A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia. Proc Natl Acad Sci U S A (1987) 1.73
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (2000) 1.66
Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch Dis Child (1983) 1.64
HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol (1986) 1.63
Transgenic tobacco expressing Vitreoscilla hemoglobin exhibits enhanced growth and altered metabolite production. Nat Biotechnol (1997) 1.63
DNA polymerase I is required for premeiotic DNA replication and sporulation but not for X-ray repair in Saccharomyces cerevisiae. Mol Cell Biol (1989) 1.62
Central carbon metabolism of Saccharomyces cerevisiae explored by biosynthetic fractional (13)C labeling of common amino acids. Eur J Biochem (2001) 1.56
A high-throughput alphavirus-based expression cloning system for mammalian cells. Nat Biotechnol (2001) 1.55
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther (2000) 1.52
The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations. J Virol (1995) 1.52
Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting. Pediatrics (1990) 1.52
Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab (1987) 1.50
Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease. Gastroenterology (1996) 1.49
Shared idiotypes and restricted immunoglobulin variable region heavy chain genes characterize murine autoantibodies of various specificities. J Clin Invest (1986) 1.48
The functional organization of the interictal spike complex in benign rolandic epilepsy. Epilepsia (1996) 1.45
The value of early treatment of deer tick bites for the prevention of Lyme disease. Am J Dis Child (1993) 1.43
The increasing incidence of Ampicillin-resistant Haemophilus influenzae. A cause of otitis media. JAMA (1978) 1.40
Continuous intraventricular pressure monitoring for diagnosis of normal-pressure hydrocephalus. Acta Neurochir (Wien) (2007) 1.40
Bioreaction network topology and metabolic flux ratio analysis by biosynthetic fractional 13C labeling and two-dimensional NMR spectroscopy. Metab Eng (1999) 1.39
Wavelength-dependent measurements of optical-fiber transit time, material dispersion, and attenuation. Appl Opt (2001) 1.39
Metabolic flux analysis with a comprehensive isotopomer model in Bacillus subtilis. Biotechnol Bioeng (2001) 1.39
One lung anaesthesia for video assisted thoracoscopic lung biopsy in a paediatric patient. Paediatr Anaesth (1999) 1.39
[Special prosthesis implant with partial femoral replacement. Operation after periprosthetic femoral fracture and ipsilateral long-stem knee prosthesis and fixed-angle osteosynthesis]. Unfallchirurg (2014) 1.39
Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Biochemistry (1986) 1.39
Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother (1994) 1.39
A segregated model of recombinant multicopy plasmid propagation. Biotechnol Bioeng (1988) 1.38
Results of radiotherapy of subfoveal neovascularization with 16 and 20 Gy. Eye (Lond) (2005) 1.38
Heterologous expression of a bacterial haemoglobin improves the growth properties of recombinant Escherichia coli. Nature (1988) 1.37
Metabolic capacity of Bacillus subtilis for the production of purine nucleosides, riboflavin, and folic acid. Biotechnol Bioeng (1998) 1.35
Effects of hyperinsulinemia in the primate fetus. Diabetes (1985) 1.34
Effect of information about waiting lists on referral patterns of general practitioners. Br J Gen Pract (1990) 1.34
Transport of lactate and acetate through the energized cytoplasmic membrane of Escherichia coli. Biotechnol Bioeng (1995) 1.33
Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J Biomed Mater Res (1997) 1.33
Physiology and metabolic fluxes of wild-type and riboflavin-producing Bacillus subtilis. Appl Environ Microbiol (1996) 1.33
Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer (1987) 1.30
MCA has more to say. J Theor Biol (1996) 1.30
Flow cytometry analysis of recombinant Saccharomyces cerevisiae populations. Cytometry (1986) 1.29
Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol (2001) 1.27
Sources of fatty acids in the newborn. Pediatrics (1971) 1.26
Influence of low temperature on productivity, proteome and protein phosphorylation of CHO cells. Biotechnol Bioeng (1999) 1.26
Laparoscopic pancreatic surgery. Am J Surg (1999) 1.25
Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol (1997) 1.25
A novel cytostatic process enhances the productivity of Chinese hamster ovary cells. Biotechnol Bioeng (1997) 1.23
Chronic hyperinsulinemia in the fetal rhesus monkey. Effects of physiologic hyperinsulinemia on fetal growth and composition. Diabetes (1984) 1.22
Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology (1994) 1.22
Percutaneous indwelling radial-artery catheters for monitoring cardiovascular function. Prospective study of the risk of thrombosis and infection. N Engl J Med (1974) 1.21
Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. N Engl J Med (1984) 1.20
Flow microfluorometry study of diauxic batch growth of Saccharomyces cerevisiae. Appl Environ Microbiol (1978) 1.20
Self-expanding nitinol stents in canine vertebral arteries: hemodynamics and tissue response. AJNR Am J Neuroradiol (1995) 1.20
Persistent glucose production during glucose infusion in the neonate. J Clin Invest (1983) 1.18
A novel rat carboxypeptidase, CPA2: characterization, molecular cloning, and evolutionary implications on substrate specificity in the carboxypeptidase gene family. J Biol Chem (1988) 1.17
Modeling the population dynamics of baculovirus-infected insect cells: Optimizing infection strategies for enhanced recombinant protein yields. Biotechnol Bioeng (1992) 1.16
A temperature-regulated replicon-based DNA expression system. Nat Biotechnol (2000) 1.16
Human fetal insulin metabolismearly in gestation. Response to acutelevation of the fetal glucose concentration and placental tranfer of human insulin-I-131. Diabetes (1969) 1.15
Active pulmonary tuberculosis with negative tuberculin skin reactions. Am Rev Respir Dis (1967) 1.15
The nasopharyngeal culture in acute otitis media. A reappraisal of its usefulness. JAMA (1979) 1.15
Dose-related activity of stavudine in patients infected with human immunodeficiency virus. J Infect Dis (1995) 1.14
Evaluating programs for recruiting and retaining community faculty. Fam Med (1999) 1.14
Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses. J Clin Invest (1981) 1.13
Engaging hospitalized heroin-dependent patients into substance abuse treatment. J Subst Abuse Treat (1999) 1.13
Factors influencing recombinant protein yields in an insect cell-bacuiovirus expression system: multiplicity of infection and intracellular protein degradation. Biotechnol Bioeng (1991) 1.13
Formation of free acetate by isolated perfused livers from normal, starved and diabetic rats. Biochem Biophys Res Commun (1974) 1.13
A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther (2007) 1.12
A mathematical model of N-linked glycoform biosynthesis. Biotechnol Bioeng (1997) 1.12
The Vitreoscilla hemoglobin gene: molecular cloning, nucleotide sequence and genetic expression in Escherichia coli. Mol Gen Genet (1988) 1.11
A population-based study of motorcycle injury and costs. Ann Emerg Med (1992) 1.10
Intracellular expression of Vitreoscilla hemoglobin alters Escherichia coli energy metabolism under oxygen-limited conditions. Eur J Biochem (1994) 1.10
Human fetal insulin response to sustained maternal hyperglycemia. N Engl J Med (1970) 1.09
Temporal response of immunoreactive erythropoietin to acute hypoxemia in fetal sheep. Pediatr Res (1986) 1.09
[Clarity of flight information in the cockpit of the new aircraft generation]. Ophthalmologe (1994) 1.09
Plasmid presence changes the relative levels of many host cell proteins and ribosome components in recombinant Escherichia coli. Biotechnol Bioeng (1991) 1.08
The center of the umbilicus as the Veress needle's entry site for laparoscopy. J Reprod Med (1984) 1.08
Lattice simulations of aggregation funnels for protein folding. J Comput Biol (1999) 1.08
Rapidly progressive herpetic retinal necrosis: a blinding disease characteristic of advanced AIDS. Clin Infect Dis (1998) 1.07
Autoregulated multicistronic expression vectors provide one-step cloning of regulated product gene expression in mammalian cells. Biotechnol Prog (1998) 1.07